Wednesday, February 14, 2018 3:38:30 PM
This feels like a step up in revenue after flatlining for 2 years which is good but I want them to show that they can grow revenues without growing expense. I was excited by Q2 when expenses were down sequentially by quite a bit becuase I felt if they could do that they could be a good story even if the growth doesn't come.
If I buy today I am buying in to the upside story and I'm probably early. I've been burned by that too many times. Now, I'll wait. If they get business for other drug applications thene a new release will push it up 50% overnight and most people will say damn I missed my chance. That is when I will buy. Sure I may have missed the first 100% but my odds of it being right are much better.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM